Title:
Multimodal Tissue Perfusion Assessment and Monitoring Device
Tech ID:
2021-003
Important Dates:
- Disclosure to TTO: 09/01/2020
Category:
Medical Devices, Diagnostics & Healthtech
Executive Statement:
A novel device integrating multiple imaging modalities and AI to continuously and non-invasively assess and monitor tissue perfusion for improved surgical outcomes.
Description:
This technology combines advanced imaging techniques such as thermal imaging, high-resolution video, volumetric LIDAR, and terahertz radiation signature analysis with artificial intelligence algorithms to automatically localize blood vessels and monitor tissue perfusion. It is designed to reduce physician time and costs by providing continuous, accurate, and early detection of vascular compromise in reconstructive surgery and related medical applications.
Key Advantages:
- Utilizes multiple imaging modalities for enhanced accuracy and reliability
- Employs AI to detect tissue changes earlier than traditional methods
- Non-invasive, continuous monitoring across a large tissue area
- Reduces physician time and overall clinical costs
- Applies novel imaging technologies including terahertz and thermal mapping
Problems Solved:
- Limitations and high costs of current preoperative vessel mapping techniques
- Labor-intensive and subjective postoperative tissue monitoring
- Inability to continuously monitor tissue perfusion in a non-invasive way
- Delayed detection of vascular compromise risking patient outcomes
Market Applications:
- Microsurgery planning, assessment, and monitoring
- Wound care management, especially chronic wounds and edema
- Vascular surgery and treatment of vasculopathies
- Diabetes-related tissue care and trauma/extremity salvage
- General surgery and cardiac surgery monitoring support
Lead Inventors & Contribution:
- Barry Claman
- John Menezes
- Marc Kahn
- Brendan Morris